J. Goldman & CO LP Biomarin Pharmaceutical Inc Call Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $4.09 Million - $5.07 Million
55,000 New
55,000 $4.53 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $2.48 Million - $3.2 Million
32,500 New
32,500 $3.13 Million
Q3 2020

Nov 16, 2020
SELL
$71.87 - $131.03 $618,082 - $1.13 Million
-8,600 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $684,130 - $1.07 Million
8,600 New
8,600 $1.06 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email